tiprankstipranks
Trending News
More News >
Kosei Securities Co., Ltd. (JP:8617)
:8617
Japanese Market

Kosei Securities Co., Ltd. (8617) AI Stock Analysis

Compare
0 Followers

Top Page

JP:8617

Kosei Securities Co., Ltd.

(8617)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
¥560.00
▲(23.08% Upside)
Action:UpgradedDate:01/27/26
The score is held down primarily by severe deterioration in profitability and cash flow, despite a comparatively strong, low-debt balance sheet. Technicals are supportive with strong momentum, but overbought signals raise near-term risk. Valuation provides limited support given negative earnings and a low dividend yield.
Positive Factors
Strong equity base
A 72.17% equity ratio indicates a durable capital structure that cushions operational losses and supports credibility with counterparties. Over a 2–6 month horizon this capital buffer preserves strategic optionality to invest or restructure without immediate solvency pressure.
Very low financial leverage
Near-zero debt materially reduces fixed interest burden and bankruptcy risk, giving management flexibility to fund recovery via retained capital or modest borrowing. This low leverage is a lasting structural strength during periods of cash shortfall.
High gross margin
An 86% gross margin suggests the core business or trading activities generate wide spreads before overhead. If revenue stabilizes, this structural profitability at the gross level improves prospects for restoring operating profitability through cost control and scale.
Negative Factors
Severe revenue contraction
A 62.7% year-on-year revenue collapse signals loss of scale that erodes fixed-cost coverage, client reach, and pricing power. Revenue recovery typically takes months to quarters, and prolonged contraction undermines long-term margin recovery and strategic investments.
Deep negative profitability
A net margin near -84% and negative ROE reflect persistent operating losses that destroy shareholder value and impede reinvestment. Over several months this weak profitability limits ability to rebuild reserves or fund growth without external financing or drastic structural changes.
Large free cash flow deficit
A ¥2,916m negative FCF denotes significant cash burn and weak cash conversion. Even with strong equity, sustained negative FCF pressures liquidity, forces reliance on financing or asset sales, and constrains operational investments or client service capacity over the medium term.

Kosei Securities Co., Ltd. (8617) vs. iShares MSCI Japan ETF (EWJ)

Kosei Securities Co., Ltd. Business Overview & Revenue Model

Company DescriptionThe Kosei Securities Co., Ltd. engages in the brokerage, underwriting, and selling of securities in Japan. It handles stocks, bonds, mutual funds, futures/options, real estate investment trusts, and insurance. The company was founded in 1961 and is headquartered in Osaka, Japan.
How the Company Makes MoneyKosei Securities generates revenue through multiple streams, primarily from brokerage fees on securities transactions, which include commissions earned from buying and selling stocks and other financial instruments. Additionally, the company earns income from investment advisory services provided to clients, which often includes management fees based on assets under management. Another significant revenue source is underwriting services for new equity and debt issuances, where the company helps corporations raise capital in exchange for fees. Partnerships with financial institutions and participation in large-scale investment projects also contribute to its earnings, as they allow Kosei Securities to expand its service offerings and reach a broader client base.

Kosei Securities Co., Ltd. Financial Statement Overview

Summary
Financial health is weak overall: revenues fell 62.69% and net margin is deeply negative (-83.51%) with negative EBIT/EBITDA, compounded by heavy cash burn (free cash flow -2,916M JPY). The main offset is a strong balance sheet with low leverage (equity ratio 72.17%, debt-to-equity 0.02), but profitability and cash generation remain severely impaired.
Income Statement
30
Negative
The income statement shows a concerning trend with declining revenues and significant losses. The Gross Profit Margin is healthy at 86.05% for the latest year, but the Net Profit Margin is heavily negative at -83.51% due to substantial net losses. Revenue has sharply decreased by 62.69% from the previous year, indicating a severe downturn. The negative EBIT and EBITDA margins further highlight operational inefficiencies.
Balance Sheet
70
Positive
The balance sheet remains robust with a strong Equity Ratio of 72.17%, indicating a solid capital structure with low leverage. The Debt-to-Equity Ratio is low at 0.02, suggesting minimal reliance on debt. However, the Return on Equity is negative at -2.97%, reflecting the company's struggle to generate returns for shareholders amidst losses.
Cash Flow
25
Negative
The cash flow statement reveals severe challenges, with a significant negative Free Cash Flow of -2,916 million yen and a sharp decline from the previous year. The Operating Cash Flow to Net Income Ratio is negative, underscoring the cash burn and inability to convert sales into cash. The Free Cash Flow to Net Income Ratio also highlights inefficiencies in cash management.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue600.00M558.00M1.50B433.00M443.00M1.11B
Gross Profit525.00M480.00M1.44B417.00M425.00M1.07B
EBITDA-410.00M-462.00M496.00M-442.00M-404.00M208.00M
Net Income-444.00M-466.00M377.00M-397.00M-212.00M162.00M
Balance Sheet
Total Assets27.53B21.78B24.61B21.05B20.41B22.52B
Cash, Cash Equivalents and Short-Term Investments9.07B5.45B9.22B8.49B7.39B8.20B
Total Debt474.00M353.00M268.00M359.00M515.00M615.00M
Total Liabilities11.94B6.06B7.67B5.71B4.49B5.84B
Stockholders Equity15.59B15.72B16.94B15.34B15.92B16.67B
Cash Flow
Free Cash Flow0.00-2.92B770.00M370.00M-1.10B345.00M
Operating Cash Flow0.00-2.91B831.00M383.00M-1.09B557.00M
Investing Cash Flow0.00769.00M-419.00M-160.00M205.00M-621.00M
Financing Cash Flow0.00-160.00M-47.00M-48.00M-123.00M-69.00M

Kosei Securities Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price455.00
Price Trends
50DMA
518.06
Positive
100DMA
496.42
Positive
200DMA
474.43
Positive
Market Momentum
MACD
16.57
Positive
RSI
73.95
Negative
STOCH
89.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8617, the sentiment is Positive. The current price of 455 is below the 20-day moving average (MA) of 563.75, below the 50-day MA of 518.06, and below the 200-day MA of 474.43, indicating a bullish trend. The MACD of 16.57 indicates Positive momentum. The RSI at 73.95 is Negative, neither overbought nor oversold. The STOCH value of 89.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8617.

Kosei Securities Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
81
Outperform
¥18.06B4.734.13%-9.87%4.37%
74
Outperform
¥7.45B7.994.08%-10.65%-19.65%
71
Outperform
¥73.17B14.269.22%6.15%7.45%45.25%
68
Neutral
¥54.67B14.474.86%6.40%41.18%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
65
Neutral
¥7.10B11.263.66%4.48%19.69%
50
Neutral
¥5.48B-68.511.12%-34.90%-1619.67%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:8617
Kosei Securities Co., Ltd.
580.00
152.97
35.82%
JP:8613
Marusan Securities Co., Ltd.
1,100.00
174.19
18.82%
JP:7175
Imamura Securities Co.Ltd.
1,400.00
300.20
27.30%
JP:8614
Toyo Securities Co., Ltd.
779.00
242.91
45.31%
JP:8700
Maruhachi Securities Co., Ltd.
1,780.00
173.42
10.79%
JP:8747
Yutaka Trusty Securities Co., Ltd.
3,290.00
1,747.26
113.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 27, 2026